Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.

Turnbull E, Priaulx J, van Ravesteyn NT, Heinävaara S, Siljander I, Senore C, Segnan N, Vokó Z, Hagymásy J, Jarm K, Veerus P, de Koning HJ, McKee M.

Health Policy. 2018 Aug 24. pii: S0168-8510(18)30380-4. doi: 10.1016/j.healthpol.2018.08.003. [Epub ahead of print]

PMID:
30195444
2.

Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test.

Senore C, Hassan C, Regge D, Pagano E, Iussich G, Correale L, Segnan N.

J Med Screen. 2018 Sep 4:969141318789710. doi: 10.1177/0969141318789710. [Epub ahead of print]

PMID:
30180780
3.

Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries.

Turnbull E, Priaulx J, de Kok IMCM, Lansdorp-Vogelaar I, Anttila A, Sarkeala T, Senore C, Segnan N, Csanádi M, Pitter J, Novak Mlakar D, Ivanus U, Veerus P, de Koning HJ, McKee M.

Health Policy. 2018 Aug 24. pii: S0168-8510(18)30385-3. doi: 10.1016/j.healthpol.2018.08.005. [Epub ahead of print]

PMID:
30170757
4.

Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.

Lazzaretti MG, Ponti A, Mano MP, Barca A, Casella D, Frigerio A, Giordano L, Mantellini P, Paduos A, Pitarella S, Ravaioli A, Taffurelli M, Tomatis M, Segnan N.

Breast. 2018 Aug 14;42:15-22. doi: 10.1016/j.breast.2018.08.001. [Epub ahead of print]

PMID:
30138762
5.

Author's reply to: Implementation and organization of cancer screening in France.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranaryanan R.

Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31629. [Epub ahead of print] No abstract available.

PMID:
29943811
6.

Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.

Pinsky PF, Loberg M, Senore C, Wooldrage K, Atkin W, Bretthauer M, Cross AJ, Hoff G, Holme O, Kalager M, Segnan N, Schoen RE.

Gastroenterology. 2018 Jun 20. pii: S0016-5085(18)34667-5. doi: 10.1053/j.gastro.2018.06.040. [Epub ahead of print]

PMID:
29935150
7.

Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.

Vale DB, Anttila A, Ponti A, Senore C, Sankaranaryanan R, Ronco G, Segnan N, Tomatis M, Žakelj MP, Elfström KM, Lönnberg S, Dillner J, Basu P.

Eur J Cancer Prev. 2018 Mar 21. doi: 10.1097/CEJ.0000000000000426. [Epub ahead of print]

PMID:
29570103
8.

Author's reply to: Cancer screening policy in Hungary.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Aug 15;143(4):1005. doi: 10.1002/ijc.31371. Epub 2018 Mar 30. No abstract available.

PMID:
29524204
9.

Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, Saraiya M, Segnan N, Sankaranarayanan R, Rajaraman P, Trimble E, Taplin S, Rath GK, Mehrotra R.

Lancet Oncol. 2018 Feb;19(2):e113-e122. doi: 10.1016/S1470-2045(18)30003-2. Review.

PMID:
29413465
10.

Breast Cancer Screening Frequency and Overdiagnosis.

Ponti A, Frigerio A, Marra V, Armaroli P, Segnan N.

J Am Coll Radiol. 2017 Dec;14(12):1520. doi: 10.1016/j.jacr.2017.08.043. No abstract available.

PMID:
29202932
11.

The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.

Giordano L, Gallo F, Petracci E, Chiorino G, Segnan N; Andromeda working group.

BMC Cancer. 2017 Nov 22;17(1):785. doi: 10.1186/s12885-017-3784-5.

12.

Flexible Sigmoidoscopy and CT Colonography Screening: Patients' Experience with and Factors for Undergoing Screening-Insight from the Proteus Colon Trial.

Senore C, Correale L, Regge D, Hassan C, Iussich G, Silvani M, Arrigoni A, Morra L, Segnan N.

Radiology. 2018 Mar;286(3):873-883. doi: 10.1148/radiol.2017170228. Epub 2017 Oct 17.

PMID:
29040021
13.

Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.

Segnan N, Armaroli P.

Cancer. 2017 Dec 15;123(24):4767-4769. doi: 10.1002/cncr.31032. Epub 2017 Oct 4. No abstract available.

PMID:
28976554
14.

Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10. Erratum in: Int J Cancer. 2018 Jul 1;143(1):E1.

PMID:
28940326
15.

Inequalities in cervical cancer screening utilisation and results: A comparison between Italian natives and immigrants from disadvantaged countries.

Gallo F, Caprioglio A, Castagno R, Ronco G, Segnan N, Giordano L.

Health Policy. 2017 Oct;121(10):1072-1078. doi: 10.1016/j.healthpol.2017.08.005. Epub 2017 Aug 10.

PMID:
28843514
16.

Distribution of colorectal polyps: Implications for screening.

Senore C, Bellisario C, Segnan N.

Best Pract Res Clin Gastroenterol. 2017 Aug;31(4):481-488. doi: 10.1016/j.bpg.2017.04.008. Epub 2017 Apr 26. Review.

PMID:
28842058
17.

Postnatal risk factors for testicular cancer: The EPSAM case-control study.

Moirano G, Zugna D, Grasso C, Mirabelli D, Lista P, Ciuffreda L, Segnan N, Merletti F, Richiardi L.

Int J Cancer. 2017 Nov 1;141(9):1803-1810. doi: 10.1002/ijc.30884. Epub 2017 Jul 27.

PMID:
28699204
18.

[Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].

Di Stefano F, Giorgi Rossi P, Carozzi F, Ronco G, Cacciani L, Vecchi S, Naldoni C, Segnan N; Gruppo di lavoro MIDDIR – HPV test in primary screening.

Epidemiol Prev. 2017 Mar-Apr;41(2):116-124. doi: 10.19191/EP17.2.P116.031. Italian.

PMID:
28627153
19.

Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.

Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M.

BMJ. 2017 Jan 13;356:i6673. doi: 10.1136/bmj.i6673.

20.

Estimate of false-positive breast cancer diagnoses from accuracy studies: a systematic review.

Segnan N, Minozzi S, Ponti A, Bellisario C, Balduzzi S, González-Lorenzo M, Gianola S, Armaroli P.

J Clin Pathol. 2017 Apr;70(4):282-294. doi: 10.1136/jclinpath-2016-204184. Epub 2017 Jan 10. Review.

PMID:
28073996
21.

Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study.

Grasso C, Zugna D, Fiano V, Robles Rodriguez N, Maule M, Gillio-Tos A, Ciuffreda L, Lista P, Segnan N, Merletti F, Richiardi L.

PLoS One. 2016 Dec 30;11(12):e0169174. doi: 10.1371/journal.pone.0169174. eCollection 2016.

22.

A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.

Passamonti B, Malaspina M, Fraser CG, Tintori B, Carlani A, D'Angelo V, Galeazzi P, Di Dato E, Mariotti L, Bulletti S, D'Amico MR, Gustinucci D, Martinelli N, Spita N, Cesarini E, Rubeca T, Giaimo M, Segnan N, Senore C.

Gut. 2018 Mar;67(3):485-496. doi: 10.1136/gutjnl-2016-312716. Epub 2016 Dec 14.

PMID:
27974550
23.

Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.

Ronco G, Zappa M, Franceschi S, Tunesi S, Caprioglio A, Confortini M, Del Mistro A, Carozzi F, Segnan N, Zorzi M, Giorgi-Rossi P; Italian HPV Survey Working Group.

Eur J Cancer. 2016 Nov;68:148-155. doi: 10.1016/j.ejca.2016.09.008. Epub 2016 Oct 15.

24.

Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.

Hassan C, Senore C, Radaelli F, De Pretis G, Sassatelli R, Arrigoni A, Manes G, Amato A, Anderloni A, Armelao F, Mondardini A, Spada C, Omazzi B, Cavina M, Miori G, Campanale C, Sereni G, Segnan N, Repici A.

Gut. 2017 Nov;66(11):1949-1955. doi: 10.1136/gutjnl-2016-311906. Epub 2016 Aug 9.

PMID:
27507903
25.

Comparing CT colonography and flexible sigmoidoscopy: a randomised trial within a population-based screening programme.

Regge D, Iussich G, Segnan N, Correale L, Hassan C, Arrigoni A, Asnaghi R, Bestagini P, Bulighin G, Cassinis MC, Ederle A, Ferraris A, Galatola G, Gallo T, Gandini G, Garretti L, Martina MC, Molinar D, Montemezzi S, Morra L, Motton M, Occhipinti P, Pinali L, Soardi GA, Senore C.

Gut. 2017 Aug;66(8):1434-1440. doi: 10.1136/gutjnl-2015-311278. Epub 2016 Apr 12.

26.

Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.

Segnan N, Minozzi S, Armaroli P, Cinquini M, Bellisario C, González-Lorenzo M, Gianola S, Ponti A.

Int J Cancer. 2016 Aug 1;139(3):554-73. doi: 10.1002/ijc.30105. Epub 2016 Apr 15. Review.

27.

Absence of socioeconomic inequalities in access to good-quality breast cancer treatment within a population-wide screening programme in Turin (Italy).

Zengarini N, Ponti A, Tomatis M, Casella D, Giordano L, Mano MP, Segnan N, Whitehead M, Costa G, Spadea T.

Eur J Cancer Prev. 2016 Nov;25(6):538-46. doi: 10.1097/CEJ.0000000000000211.

PMID:
26999379
28.

Baldness and testicular cancer: the EPSAM case-control study.

Moirano G, Zugna D, Grasso C, Lista P, Ciuffreda L, Segnan N, Merletti F, Richiardi L.

Andrology. 2016 Mar;4(2):251-6. doi: 10.1111/andr.12148. Epub 2016 Jan 20.

29.

[Reducing non-communicable diseases and health care costs: building a prevention alliance].

Piccinelli C, Pagano E, Segnan N.

Epidemiol Prev. 2015;39(3):202-7. Italian.

30.

European Code against Cancer, 4th Edition: Cancer screening.

Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, Dean PB, de Koning HJ, Dillner L, Herrero R, Kuipers EJ, Lansdorp-Vogelaar I, Minozzi S, Paci E, Regula J, Törnberg S, Segnan N.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S139-52. doi: 10.1016/j.canep.2015.10.021.

31.

[Integrating cancer screening and primary prevention: a review].

Giordano L, Segnan N, Mano MP, Gallo F, Bellisario C, Senore C.

Epidemiol Prev. 2015 Sep-Dec;39(5-6):360-5. Review. Italian.

32.

[Introduction of a centralised system (Service) for collecting clinical data in cancer screening programmes in Piedmont (Northern Italy): a pre-post assessment of a hub&spoke model].

Gallo F, Giubilato P, Larato C, Caprioglio A, Tomatis M, Calcagno M, Casella D, Di Leo A, Ponti A, Ronco G, Segnan N, Giordano L; Gruppo di lavoro Service.

Epidemiol Prev. 2015 Jul-Aug;39(4):243-50. Italian.

PMID:
26499237
33.

European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations.

Minozzi S, Armaroli P, Espina C, Villain P, Wiseman M, Schüz J, Segnan N.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S11-9. doi: 10.1016/j.canep.2015.08.014. Epub 2015 Oct 2.

34.

[Breast screening: efficacy, adverse effects, and communication].

Segnan N, Paci E.

Epidemiol Prev. 2015;39(3):151-3. Italian. No abstract available.

PMID:
26407465
35.

Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy, 2011-2012.

Ponti A, Mano MP, Tomatis M, Baiocchi D, Barca A, Berti R, Casella D, D'Ambrosio E, Delos E, Donati G, Falcini F, Frammartino B, Frigerio A, Giudici F, Mantellini P, Naldoni C, Olla Atzeni C, Orzalesi L, Pagano G, Pietribiasi F, Pitarella S, Ravaioli A, Silvestri A, Taffurelli M, Tidone E, Zanconati F, Segnan N.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):40-7.

36.

Breast cancer screening in Italy: evaluating key performance indicators for time trends and activity volumes.

Giordano L, Castagno R, Giorgi D, Piccinelli C, Ventura L, Segnan N, Zappa M.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):30-9.

37.

European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.

Schüz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W; Working Groups of Scientific Experts.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S1-10. doi: 10.1016/j.canep.2015.05.009. Epub 2015 Jul 9.

38.

The EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries.

Giordano L, Bisanti L, Salamina G, Ancelle Park R, Sancho-Garnier H, Espinas J, Berling C, Rennert G, Castagno R, Dotti M, Jaramillo L, Segnan N; Euromed Cancer working group.

Eur J Public Health. 2016 Feb;26(1):83-9. doi: 10.1093/eurpub/ckv107. Epub 2015 Jun 13.

PMID:
26072520
39.

Optimising colorectal cancer screening acceptance: a review.

Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C.

Gut. 2015 Jul;64(7):1158-77. doi: 10.1136/gutjnl-2014-308081. Epub 2015 Apr 8. Review.

PMID:
26059765
40.

Histological features of advanced colorectal adenomas detected by endoscopy and fecal immunochemical test.

Risio M, Hassan C, Sottile A, Saglia A, Segnan N, Senore C.

Endoscopy. 2015 Oct;47(10):903-9. doi: 10.1055/s-0034-1392203. Epub 2015 May 28.

PMID:
26021311
41.

Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.

Senore C, Ederle A, DePretis G, Magnani C, Canuti D, Deandrea S, Zorzi M, Barca A, Bestagini P, Faitini K, Bisanti L, Casale C, Ferro A, GiorgiRossi P, Quadrino F, Fiorina G, Capuano A, Segnan N, Fantin A.

Prev Med. 2015 Apr;73:106-11. doi: 10.1016/j.ypmed.2015.01.005. Epub 2015 Jan 17.

PMID:
25602908
42.

Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.

Bergeron C, Giorgi-Rossi P, Cas F, Schiboni ML, Ghiringhello B, Dalla Palma P, Minucci D, Rosso S, Zorzi M, Naldoni C, Segnan N, Confortini M, Ronco G.

J Natl Cancer Inst. 2015 Jan 7;107(2). pii: dju423. doi: 10.1093/jnci/dju423. Print 2015 Feb.

43.

Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial.

Senore C, Bonelli L, Sciallero S, Casella C, Santarelli A, Armaroli P, Zanetti R, Segnan N.

J Natl Cancer Inst. 2014 Dec 9;107(1):385. doi: 10.1093/jnci/dju385. Print 2015 Jan.

PMID:
25492939
44.

International variation in management of screen-detected ductal carcinoma in situ of the breast.

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.

45.

Multitarget stool DNA testing for colorectal-cancer screening.

Senore C, Segnan N.

N Engl J Med. 2014 Jul 10;371(2):185-6. doi: 10.1056/NEJMc1405215. No abstract available.

PMID:
25006738
46.

Narrow band imaging vs. high definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: a randomised trial.

Senore C, Reggio D, Musso A, Bruno M, De Angelis C, Giordanino C, Coppo C, Tari R, Pagliarulo M, Carmagnola S, Montino F, Silvani M, Segnan N, Rizzetto M, Saracco GM.

Dig Liver Dis. 2014 Sep;46(9):803-7. doi: 10.1016/j.dld.2014.05.007. Epub 2014 Jun 6.

PMID:
24908572
47.

HPV-based screening for prevention of invasive cervical cancer - Authors' reply.

Ronco G, Meijer CJ, Segnan N, Kitchener H, Giorgi-Rossi P, Peto J, Dillner J.

Lancet. 2014 Apr 12;383(9925):1295. doi: 10.1016/S0140-6736(14)60645-0. No abstract available.

PMID:
24725577
48.

Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.

Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N.

Trials. 2014 Mar 28;15:97. doi: 10.1186/1745-6215-15-97.

49.

Computer-aided detection for computed tomographic colonography screening: a prospective comparison of a double-reading paradigm with first-reader computer-aided detection against second-reader computer-aided detection.

Iussich G, Correale L, Senore C, Hassan C, Segnan N, Campanella D, Bert A, Galatola G, Laudi C, Regge D.

Invest Radiol. 2014 Mar;49(3):173-82. doi: 10.1097/RLI.0000000000000009.

50.

Lifetime growth and risk of testicular cancer.

Richiardi L, Vizzini L, Pastore G, Segnan N, Gillio-Tos A, Fiano V, Grasso C, Ciuffreda L, Lista P, Pearce N, Merletti F.

Int J Cancer. 2014 Aug 1;135(3):695-701. doi: 10.1002/ijc.28688. Epub 2014 Jan 10.

Supplemental Content

Loading ...
Support Center